List of BioLaminaa patents

List of BioLaminaa patents

List of Daicel patents

List of Natrix Separations patents

List of Sound United patents

CEOs of wholesale telecommunications companies

Credit (finance) venture capital investors

Patents where

Current Assignee

Name

is

‌

BioLaminaa

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 8415156 Recombinant laminin-521	Patent 8415156 was granted and assigned to BioLamina AB on April, 2013 by the United States Patent and Trademark Office.		‌ BioLaminaa		United States Patent and Trademark Office	8415156	April 9, 2013
	‌ US Patent 10138292 Cell culture medium	Patent 10138292 was granted and assigned to BioLamina AB on November, 2018 by the United States Patent and Trademark Office.		‌ BioLaminaa		United States Patent and Trademark Office	10138292	November 27, 2018
	‌ US Patent 11767509 Methods of producing RPE cells	Patent 11767509 was granted and assigned to BioLamina AB on September, 2023 by the United States Patent and Trademark Office.	‌ BioLaminaa	‌ BioLaminaa		United States Patent and Trademark Office	11767509	September 26, 2023
	‌ US Patent 10240124 Cell culture substrate comprising a laminin and a cadherin	Patent 10240124 was granted and assigned to BioLamina AB on March, 2019 by the United States Patent and Trademark Office.	‌ BioLaminaa	‌ BioLaminaa		United States Patent and Trademark Office	10240124	March 26, 2019
	‌ US Patent 10889801 Methods of producing RPE cells	Patent 10889801 was granted and assigned to BioLamina AB on January, 2021 by the United States Patent and Trademark Office.	‌ BioLaminaa	‌ BioLaminaa		United States Patent and Trademark Office	10889801	January 12, 2021
	‌ US Patent 10344259 Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases	Patent 10344259 was granted and assigned to BioLamina AB on July, 2019 by the United States Patent and Trademark Office.	‌ BioLaminaa	‌ BioLaminaa		United States Patent and Trademark Office	10344259	July 9, 2019
	‌ US Patent 11236302 Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases	Patent 11236302 was granted and assigned to BioLamina AB on February, 2022 by the United States Patent and Trademark Office.	‌ BioLaminaa	‌ BioLaminaa		United States Patent and Trademark Office	11236302	February 1, 2022
	‌ US Patent 9828630 Methods of enhancing genetic diagnosis	Patent 9828630 was granted and assigned to BioLamina AB on November, 2017 by the United States Patent and Trademark Office.	‌ BioLaminaa	‌ BioLaminaa		United States Patent and Trademark Office	9828630	November 28, 2017
	‌ US Patent 9719066 Stem cell bank	Patent 9719066 was granted and assigned to BioLamina AB on August, 2017 by the United States Patent and Trademark Office.	‌ BioLaminaa	‌ BioLaminaa		United States Patent and Trademark Office	9719066	August 1, 2017
	‌ US Patent 9499794 Maintenance of differentiated cells with laminins	Patent 9499794 was granted and assigned to BioLamina AB on November, 2016 by the United States Patent and Trademark Office.		‌ BioLaminaa		United States Patent and Trademark Office	9499794	November 22, 2016
	‌ US Patent 11155781 Maintenance of differentiated cells with laminins	Patent 11155781 was granted and assigned to BioLamina AB on October, 2021 by the United States Patent and Trademark Office.	‌ BioLaminaa	‌ BioLaminaa		United States Patent and Trademark Office	11155781	October 26, 2021
	‌ US Patent 9534038 Isolated laminin-421	Patent 9534038 was granted and assigned to BioLamina AB on January, 2017 by the United States Patent and Trademark Office.		‌ BioLaminaa		United States Patent and Trademark Office	9534038	January 3, 2017
	‌ US Patent 10829733 Composition and method for enabling proliferation of pluripotent human stem cells			‌ BioLaminaa		United States Patent and Trademark Office	10829733	November 10, 2020

13 results

0 selected

13 results

0 selected